Jacksonville (1)

Phoenix (1)

Rochester (1)

Mesothelin Positive (1)

Stage III Non-Small Cell Lung Cancer AJCC v7 (1)

Stage IIIA Non-Small Cell Lung Cancer AJCC v7 (1)

Stage IIIB Non-Small Cell Lung Cancer AJCC v7 (1)

Stage IV Non-Small Cell Lung Cancer AJCC v7 (1)

Terminated (1)

phase 1 (1)

Mayo Clinic (1)

National Cancer Institute (NCI) (1)

anetumab ravtansine (1)

atezolizumab (1)

laboratory biomarker analysis (1)

biological (1)

other (1)

Other (1)

Interventional (1)

mesothelin positive

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Terminated

Jan 5, 2023